Analysts’ Viewpoint on Market Scenario
North America is expected to offer lucrative opportunities to the market players. This is due to rising geriatric population and increasing prevalence of cancer, diabetes, and cardiovascular diseases.
The surge in demand for home healthcare services across the globe is creating potential growth prospects for players in the point-of-care diagnostics market.
Moreover, rise in prevalence of infectious diseases such as HIV/AIDS and malaria is expected to drive the demand for point-of-care diagnostics. Favorable reimbursement policies are responsible for the rapid expansion of the global market during the forecast period.
R&D activities have a large part to play in strengthening the growth structure of the point of care diagnostics market. The players indulge in these activities for adding new technologies to the systems. Furthermore, the activities also assist in increasing the revenues of the players in the market.
Strategic collaborations have a major role in expanding the landscape of the point-of-care diagnostics industry. Mergers, acquisitions, joint ventures, and partnerships are important in boosting the influence of the players in various regional pockets. These collaborations also aid in increasing the production capacities of the players in the market, eventually accelerating the growth prospects.
A blend of biosensors in point-of-care diagnostics devices help improve patient care via real-time and remote health monitoring. Furthermore, label-based techniques are time consuming and cause many complexities. These factors are accelerating the use of point-of-care diagnostics devices, ultimately contributing to the growth structure of the point-of-care diagnostics market.
Point-of-care diagnostics helps healthcare practitioners to efficiently and accurately attain real-time and high-quality results in a short span. These diagnostics help physicians, clinicians, and other healthcare professionals to make quick decisions related to the line of treatment to be given to a patient.
The North America market is expected to account for the largest share of the global market. This can be attributed to the availability of advanced healthcare infrastructure and technological growth.
The market for point-of-care diagnostics in Asia Pacific is projected to expand at a rapid pace during the forecast period. The region is expected to gain market share due to rising population, government initiatives to provide better health care facilities, growing number of patients affected by various viral diseases. Rise in disposable income of people also contributes to the expansion of the market in Asia Pacific.
Due to the COVID-19 pandemic, an increase in the strain on the healthcare sector was witnessed due to increased hospitalization and complications among many individuals. These aspects are encouraging many government bodies to improve their healthcare infrastructure. This, in turn, is propelling the growth of the point-of-care diagnostics market.
The advantages associated with point-of-care diagnostics devices are estimated to have a positive impact on the growth trajectory of the market during the forecast period. Manufacturers operating in the global point-of-care diagnostics industry are focusing on innovations in services to boost the global market.
Companies in the global market are accelerating product development and unlocking revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services arms to gain competitive edge in healthcare sector.
The COVID-19 pandemic has changed the growth equation of many industries and sectors in different ways. The growth projections of the market have also been affected due to the pandemic.
Numerous countries are ramping up COVID-19 testing measures for early detection and death prevention due to the infection. The novel coronavirus, if detected at a later stage, may spread at a rapid rate and also infect the lungs, which can prove to be dangerous, or even fatal in some cases. Hence, government bodies are upgrading COVID-19 testing measures. These factors assure accelerated growth of the point of care diagnostics market.
The benefits attached to the use of point-of-care diagnostics as compared to other techniques are predicted to strengthen the growth prospects of the global market. Other aspects such as precision, accuracy, and enhanced sensitivity assist in increasing the growth rate of the market.
| Attribute | Detail |
|---|---|
| Market Size Value in 2020 | US$ 34.1 Bn |
| Market Forecast Value in 2028 | US$ 66.0 Bn |
| Growth Rate (CAGR) | 4.7% |
| Forecast Period | 2021–2028 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Point-of-Care Diagnostics Market – Segmentation
| Attribute | Detail |
|---|---|
| Platform |
|
| Application |
|
| End-user |
|
| Region |
|
The global market is expected to reach the value of US$ 66 Bn by the end of 2028
The global market is estimated to expand at a CAGR of 4.7% from 2021 to 2028
Point-of-care diagnostics market is driven by rise in prevalence of infectious diseases such as HIV/AIDS and malaria
The lateral flow assays segment accounted for the largest share of the global point-of-care diagnostics market
Key players in the global market include Johnson & Johnson Services, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Point-of-Care Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Point-of-Care Diagnostics Market Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Technological Advancements
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Platform
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Platform, 2017-2028
6.3.1. Lateral Flow Assays
6.3.2. Dipsticks
6.3.3. Microfluidics
6.3.4. Molecular Diagnostics
6.3.5. Immunoassays
6.3.6. Others
6.4. Market Attractiveness Analysis, by Platform
7. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2028
7.3.1. Glucose Monitoring Products
7.3.2. Cardiometabolic Monitoring Products
7.3.3. Infectious Disease Testing Products
7.3.4. Pregnancy & Fertility Testing Products
7.3.5. Urinalysis Testing Products
7.3.6. Cholesterol Testing Products
7.3.7. Hematology Testing Products
7.3.8. Drugs-of-abuse Testing Products
7.3.9. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Point-of-Care Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2028
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Clinics/Physician Offices
8.3.4. Home Care
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Point-of-Care Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Platform, 2017-2028
10.2.1. Lateral Flow Assays
10.2.2. Dipsticks
10.2.3. Microfluidics
10.2.4. Molecular Diagnostics
10.2.5. Immunoassays
10.2.6. Others
10.3. Market Value Forecast, by Application, 2017-2028
10.3.1. Glucose Monitoring Products
10.3.2. Cardiometabolic Monitoring Products
10.3.3. Infectious Disease Testing Products
10.3.4. Pregnancy & Fertility Testing Products
10.3.5. Urinalysis Testing Products
10.3.6. Cholesterol Testing Products
10.3.7. Hematology Testing Products
10.3.8. Drugs-of-abuse Testing Products
10.3.9. Others
10.4. Market Value Forecast, by End-user, 2017-2028
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Clinics/Physician Offices
10.4.4. Home Care
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017-2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Platform
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Point-of-Care Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Platform, 2017-2028
11.2.1. Lateral Flow Assays
11.2.2. Dipsticks
11.2.3. Microfluidics
11.2.4. Molecular Diagnostics
11.2.5. Immunoassays
11.2.6. Others
11.3. Market Value Forecast, by Application, 2017-2028
11.3.1. Glucose Monitoring Products
11.3.2. Cardiometabolic Monitoring Products
11.3.3. Infectious Disease Testing Products
11.3.4. Pregnancy & Fertility Testing Products
11.3.5. Urinalysis Testing Products
11.3.6. Cholesterol Testing Products
11.3.7. Hematology Testing Products
11.3.8. Drugs-of-abuse Testing Products
11.3.9. Others
11.4. Market Value Forecast, by End-user, 2017-2028
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Clinics/Physician Offices
11.4.4. Home Care
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-Region, 2017-2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Platform
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Platform, 2017-2028
12.2.1. Lateral Flow Assays
12.2.2. Dipsticks
12.2.3. Microfluidics
12.2.4. Molecular Diagnostics
12.2.5. Immunoassays
12.2.6. Others
12.3. Market Value Forecast, by Application, 2017-2028
12.3.1. Glucose Monitoring Products
12.3.2. Cardiometabolic Monitoring Products
12.3.3. Infectious Disease Testing Products
12.3.4. Pregnancy & Fertility Testing Products
12.3.5. Urinalysis Testing Products
12.3.6. Cholesterol Testing Products
12.3.7. Hematology Testing Products
12.3.8. Drugs-of-abuse Testing Products
12.3.9. Others
12.4. Market Value Forecast, by End-user, 2017-2028
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Clinics/Physician Offices
12.4.4. Home Care
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-Region, 2017-2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Platform
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Point-of-Care Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Platform, 2017-2028
13.2.1. Lateral Flow Assays
13.2.2. Dipsticks
13.2.3. Microfluidics
13.2.4. Molecular Diagnostics
13.2.5. Immunoassays
13.2.6. Others
13.3. Market Value Forecast, by Application, 2017-2028
13.3.1. Glucose Monitoring Products
13.3.2. Cardiometabolic Monitoring Products
13.3.3. Infectious Disease Testing Products
13.3.4. Pregnancy & Fertility Testing Products
13.3.5. Urinalysis Testing Products
13.3.6. Cholesterol Testing Products
13.3.7. Hematology Testing Products
13.3.8. Drugs-of-abuse Testing Products
13.3.9. Others
13.4. Market Value Forecast, by End-user, 2017-2028
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Clinics/Physician Offices
13.4.4. Home Care
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-Region, 2017-2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Platform
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Platform, 2017-2028
14.2.1. Lateral Flow Assays
14.2.2. Dipsticks
14.2.3. Microfluidics
14.2.4. Molecular Diagnostics
14.2.5. Immunoassays
14.2.6. Others
14.3. Market Value Forecast, by Application, 2017-2028
14.3.1. Glucose Monitoring Products
14.3.2. Cardiometabolic Monitoring Products
14.3.3. Infectious Disease Testing Products
14.3.4. Pregnancy & Fertility Testing Products
14.3.5. Urinalysis Testing Products
14.3.6. Cholesterol Testing Products
14.3.7. Hematology Testing Products
14.3.8. Drugs-of-abuse Testing Products
14.3.9. Others
14.4. Market Value Forecast, by End-user, 2017-2028
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Clinics/Physician Offices
14.4.4. Home Care
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-Region, 2017-2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Platform
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
15.3.1.2. Financials
15.3.1.3. Recent Developments & Strategy
15.3.1.4. SWOT Analysis
15.3.2. bioMérieux SA
15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
15.3.2.2. Financials
15.3.2.3. Recent Developments & Strategy
15.3.2.4. SWOT Analysis
15.3.3. Johnson & Johnson Services, Inc.
15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
15.3.3.2. Financials
15.3.3.3. Recent Developments & Strategy
15.3.3.4. SWOT Analysis
15.3.4. Cardinal Health, Inc.
15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
15.3.4.2. Financials
15.3.4.3. Recent Developments & Strategy
15.3.4.4. SWOT Analysis
15.3.5. Siemens AG
15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
15.3.5.2. Financials
15.3.5.3. Recent Developments & Strategy
15.3.5.4. SWOT Analysis
15.3.6. Bio Rad Laboratories, Inc.
15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
15.3.6.2. Financials
15.3.6.3. Recent Developments & Strategy
15.3.6.4. SWOT Analysis
15.3.7. BD
15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
15.3.7.2. Financials
15.3.7.3. Recent Developments & Strategy
15.3.7.4. SWOT Analysis
15.3.8. Abbott
15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
15.3.8.2. Financials
15.3.8.3. Recent Developments & Strategy
15.3.8.4. SWOT Analysis
15.3.9. Danaher Corporation
15.3.9.1. Overview (HQ, Employee Strength, Business Segments)
15.3.9.2. Financials
15.3.9.3. Recent Developments & Strategy
15.3.9.4. SWOT Analysis
15.3.10. Thermo Fisher Scientific, Inc.
15.3.10.1. Overview (HQ, Employee Strength, Business Segments)
15.3.10.2. Financials
15.3.10.3. Recent Developments & Strategy
15.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 02: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 03: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
Table 04: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2028
Table 05: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2028
Table 06: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 07: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 08: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
Table 09: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2028
Table 10: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 11: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 12: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
Table 13: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
Table 14: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 15: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 16: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
Table 17: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
Table 18: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 19: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 20: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
Table 21: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
Table 22: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017-2028
Table 23: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2028
Table 24: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2028
List of Figures
Figure 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 02: Point-of-Care Diagnostics Market Value Share, by Platform, 2020
Figure 03: Point-of-Care Diagnostics Market Value Share, by Application, 2020
Figure 04: Point-of-Care Diagnostics Market Value Share, by End-user, 2020
Figure 05: Global Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 06: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 07: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Lateral Flow Assays, 2017-2028
Figure 08: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Dipsticks, 2017-2028
Figure 09: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Microfluidics, 2017-2028
Figure 10: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017-2028
Figure 11: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Immunoassays, 2017-2028
Figure 12: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Others, 2017-2028
Figure 13: Global Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 14: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 15: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Glucose Monitoring Products, 2017-2028
Figure 16: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cardiometabolic Monitoring Products, 2017-2028
Figure 17: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Infectious Disease Testing Products, 2017-2028
Figure 18: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Pregnancy & Fertility Testing Products, 2017-2028
Figure 19: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Urinalysis Testing Products, 2017-2028
Figure 20: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cholesterol Testing Products, 2017-2028
Figure 21: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hematology Testing Products, 2017-2028
Figure 22: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Drugs-of-abuse Testing Products, 2017-2028
Figure 23: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017-2028
Figure 24: Global Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 25: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 26: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2028
Figure 27: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017-2028
Figure 28: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Clinics/Physician Offices, 2017-2028
Figure 29: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Home Care, 2017-2028
Figure 30: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017-2028
Figure 31: Global Point-of-Care Diagnostics Market Value Share Analysis, by Region, 2020 and 2028
Figure 32: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Region, 2021-2028
Figure 33: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 34: North America Point-of-Care Diagnostics Market Value Share Analysis, by Country, 2020 and 2028
Figure 35: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country, 2021-2028
Figure 36: North America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 37: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 38: North America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 39: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 40: North America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 41: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 42: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 43: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
Figure 44: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 45: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 46: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 47: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 48: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 49: Europe Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 50: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 51: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 52: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 53: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 54: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 55: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 56: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 57: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 58: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 59: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 60: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 61: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
Figure 62: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028
Figure 63: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 64: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 65: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 66: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 67: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 68: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 69: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017-2028
Figure 70: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
Figure 71: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028
Figure 72: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028
Figure 73: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021-2028
Figure 74: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028
Figure 75: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021-2028
Figure 76: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028
Figure 77: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Point-of-Care Diagnostics Market
